|Bid||92.01 x 200|
|Ask||99.99 x 800|
|Day's Range||93.50 - 96.22|
|52 Week Range||76.41 - 100.15|
|Beta (3Y Monthly)||0.63|
|PE Ratio (TTM)||59.12|
|Earnings Date||Feb 19, 2019|
|Forward Dividend & Yield||2.00 (2.12%)|
|1y Target Est||104.32|
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period […]
BRAMPTON, ON , Dec. 7, 2018 /CNW/ - Medtronic of Canada Ltd., an indirect subsidiary of Medtronic plc (MDT) announced today that it has been recognized as one of the Greater Toronto's Top Employers for 2019. Medtronic's philanthropic and employee-led activities, along with a top tier benefits package, are among some of the many reasons Medtronic is considered a top employer. The Medtronic Mission is another reason why people join and stay at Medtronic.
NEW YORK, Dec. 07, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
December 7, 2018 - The board of directors of Medtronic plc (MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2018. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 41 consecutive years.
Do shareholders automatically get shares in the new company? Or cash? Or does one need to actively do something to make it all happen?
If you are looking for the best ideas for your portfolio you may want to consider some of Jeffrey Talpins’ third quarter top stock picks. For those of you who never heard of Jeffrey Talpins, we’ll provide some basic background. He is the founder and portfolio manager of one of the biggest hedge funds that […]
Medtronic Plc said on Tuesday it would pay $50.9 million to resolve U.S. Justice Department probes into how companies it later acquired marketed medical devices, including one meant to treat a vascular defect in the brain. As part of the accord, ev3 Inc, which Medtronic now owns, will pay $17.9 million and plead guilty to a charge related to its marketing of a neurovascular medical device for unproven and potentially dangerous uses, federal prosecutors in Boston said. The misdemeanor charge relates to the Onyx Liquid Embolic System, which the U.S. Food and Drug Administration in 2005 approved for the limited use of blocking blood flow to arteriovenous malformations in the brain.
December 4, 2018 - Medtronic (MDT) is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action on September 19, 2018. A Puritan Bennett 980 ventilator is a mechanical ventilator used to support a patient`s breathing. The voluntary field corrective action is a software update to address customer feedback.
Surgical robots are increasingly being placed in hospital operating rooms. AlphaCentric Global Innovation's portfolio manager names a few investment opportunities in this fast-growing space.
AI is the buzzword these days, and the market has huge growth potential. PR Newswire, citing QY Research, reported that the global AI market could grow 52.6% (compounded annually) from $2.65 billion in 2017 to $78 billion by 2025. IBM (IBM) has been the largest player in the AI market.
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll look at Medtronic plc’s (NYSE:MDT) P/E ratio and reflect on Read More...
December 3, 2018 - Medtronic plc (MDT) today announced the first patient treated in the TERMINATE AF trial, a multi-center study evaluating two surgical ablation devices - the Cardioblate(TM) Irrigated RF (IRF) System and the CryoFlex(TM) Surgical Ablation System - for the treatment of non-paroxysmal (persistent or longstanding persistent) atrial fibrillation (AF) in patients undergoing open-heart surgical procedures. Following investigational device exemption (IDE) approval by the U.S. Food and Drug Administration (FDA), the first patient was treated in the study by the heart team led by Ralph Damiano, M.D., at Washington University School of Medicine in St. Louis.
On November 26, Abiomed (ABMD) stock closed at $311.15, a ~3.92% rise from its previous day’s close of $299.41 on November 23. Abiomed stock rose from $187.41 at the close of market on December 29, 2017, to $311.15 at the close of market on November 26, 2018, reflecting a ~66% year-to-date rise.
When Polly Varnado's 9-year-old daughter was diagnosed with Type 1 diabetes, it didn't take long for the family to hear about insulin pumps. "They said it wasn't the insulin pump, it was my daughter," said Varnado, who became a registered nurse so that she could better care for the girl. When it comes to medical devices, none have had more reported problems over the last decade than insulin pumps, a product that's used by hundreds of thousands of diabetics around the world, many of them children.
The pending acquisition of Mazor Robotics holds great potential as it is likely to solidify Medtronic's (MDT) position in robotic spine surgery.
Among the 15 analysts covering Dentsply Sirona (XRAY) in November, five analysts gave a “buy” or a higher recommendation, while ten analysts gave a “hold” recommendation. The mean rating for Dentsply stock is 2.53 with a target price of $46.73, which implies an upside potential of 28% over the closing price of $36.51 on November 23. Peers’ ratings
Desperate for relief after years of agony, Jim Taft listened intently as his pain management doctor described a medical device that could change his life. Taft's stimulator failed soon after it was surgically implanted. For years, medical device companies and doctors have touted spinal-cord stimulators as a panacea for millions of patients suffering from a wide range of pain disorders, making them one of the fastest-growing products in the $400 billion medical device industry.
WASHINGTON (AP) — To all the world, it looked like breast implants were safe. From 2008 to 2015, the U.S. Food and Drug Administration publicly reported 200 or so complaints annually — a tiny fraction of the hundreds of thousands of implant surgeries performed each year.
Medical devices have been linked to more than 1.7 million injuries and nearly 83,000 deaths in reports to U.S. regulators from manufacturers, doctors and others since 2008, the review from the International Consortium of Investigative Journalists said. Medtronic Plc figured prominently in the study, which found that one in five adverse event reports filed last year with U.S regulators was linked to a device from the company. Key InsightsGlobally, the ICIJ report found that some medical devices are approved too quickly by regulators sometimes with no human testing, and flawed products aren’t yanked from hospitals fast enough.